In the pharmaceutical and healthcare sectors, Anti-Cancer (Oncology) drugs are a critical class of pharmaceuticals designed to inhibit the growth and spread of malignant cells. In 2026, this sector is the fastest-growing therapeutic area, with the global oncology market projected to exceed $286 Billion this year as the industry shifts toward precision medicine and immunotherapy.
1. Major Classifications of Anti-Cancer Drugs
The treatment of cancer has evolved from broad-spectrum toxins to highly specific targeted molecules.
| Category | Mechanism of Action | Common Examples |
| Cytotoxic Chemotherapy | Damages or kills rapidly dividing cells (both cancerous and healthy). | Paclitaxel, Cisplatin, Doxorubicin. |
| Targeted Therapy | Specifically blocks the proteins or genes that help cancer grow. | Imatinib, Trastuzumab (Herceptin), Palbociclib. |
| Immunotherapy | Stimulates the body’s own immune system to recognize and attack cancer. | Pembrolizumab (Keytruda), Nivolumab (Opdivo). |
| Hormonal Therapy | Blocks the body’s ability to produce hormones that fuel certain cancers. | Tamoxifen, Letrozole, Bicalutamide. |
| Antibody-Drug Conjugates (ADCs) | 2026 Innovation: Combines targeted antibodies with powerful killing agents. | Trastuzumab deruxtecan. |
2. Significance of Anti-Cancer Manufacturing in India (2026)
As of 2026, India is no longer just a generic hub; it is a global leader in high-value oncology manufacturing.
Biosimilar Revolution: With the Indian Government’s “Biopharma SHAKTI” initiative (launched in Budget 2026-27), India has become a central hub for anti-cancer biosimilars, drastically reducing the cost of biologics like monoclonal antibodies for the Global South.
Advanced Containment Technology: Manufacturing oncology drugs requires specialized High-Containment (OEB 4/5) facilities to protect both the workers and the environment from high-potency molecules. Indian CDMOs have invested heavily in isolator technology and automated fill-finish lines.
Complex Injectables Mastery: India is at the forefront of producing oncology medications in advanced formats like Pre-filled Syringes (PFS) and Lyophilized (freeze-dried) Vials, which are essential for maintaining the stability of fragile cancer proteins.
Regulatory Supremacy: In 2026, Indian oncology plants lead the world in USFDA and EU-GMP certifications outside the US, ensuring that anti-cancer drugs made in India meet the highest global quality standards.
3. Why Healthy Inc. is Your Strategic Oncology Partner
Navigating the high-stakes oncology market requires a partner who understands the technical “Zero-Error” requirement of sterile manufacturing. Healthy Inc. serves as your technical gateway.
Strategic Sourcing Hub: We are associated with multiple state-of-the-art manufacturing units featuring dedicated Oncology Blocks. Whether you need Cytotoxic Injectables, Targeted Therapy Tablets, or Hormonal Preparations, we match you with the right facility.
Pharmacist-Led Technical Vetting: We provide “straight answers” on drug stability and impurity profiles. Our team vets every batch to ensure 99.9% purity, which is critical for patient safety in high-potency cancer care.
Regulatory & Dossier Mastery: We simplify international registration by providing full CTD/ACTD dossiers, stability data for all climate zones, and bioequivalence reports required for global tenders.
Global Export Logistics: Oncology drugs often require strict temperature control. Healthy Inc. ensures your shipment is managed via Validated Cold-Chain Logistics, ensuring potency from the factory to the hospital pharmacy.
Showing all 26 results
Abiraterone acetate Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths designed for high-dose oncology regimens.
Active Ingredient Strength Primary Clinical Function Abiraterone Acetate USP/Ph.Eur. 250 mg The Standard Unit: Used in a 4-tablet daily regimen to reach the 1000 mg therapeutic dose. Abiraterone Acetate USP/Ph.Eur. 500 mg The High-Compliance Unit: Reduces “pill burden” for elderly patients (2 tablets daily). Excipients Micronized Matrix Enhanced Bioavailability: Engineered to ensure consistent absorption of this lipophilic (fat-soluble) molecule. Altretamine Capsules
FreeAltretamine capsules are antineoplastic (chemotherapy) medications used primarily for the palliative treatment of advanced ovarian cancer. They are most commonly available in a 50 mg strength.
Bleomycin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder in glass vials. Potency is measured in USP Units, not milligrams.
Active Ingredient Strength Therapeutic Role Bleomycin Sulphate USP/IP 15 Units (approx. 15 mg) Antineoplastic Antibiotic Excipients Nitrogen (Inert Atmosphere) None (Pure Powder) *Pack Sizes: Single Vial Box or Tray of 10 Vials.
Bortezomib Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder in glass vials. It contains Mannitol, which forms a stable boronic ester with Bortezomib for shelf stability.
Active Ingredient Vial Strength Primary Use Bortezomib (as Mannitol Boronic Ester) 2 mg / Vial Single Dose / Low BSA Bortezomib (as Mannitol Boronic Ester) 3.5 mg / Vial Standard Adult Dose Excipients Mannitol (Sterile) Stabilizer / Bulking Agent *Pack Sizes: Single Vial Box with protective Cytotoxic shrink-wrapping.
ortezomib injection is an antineoplastic (cancer) medication supplied as a sterile lyophilised powder (freeze-dried cake) for reconstitution. It is most commonly known by the brand name Velcade.
Carboplatin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Liquid Concentrate in glass vials. It is ready to dilute.
Active Ingredient Concentration Vial Size (Total Drug) Carboplatin USP/BP 10 mg / ml 150 mg (15 ml vial) Carboplatin USP/BP 10 mg / ml 450 mg (45 ml vial) Excipients Water for Injection / Mannitol – *Pack Sizes: Single Vial Box with protective Cytotoxic shrink-wrapping.
Cisplatin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution (Liquid) in amber glass vials.
Active Ingredient Strength Concentration Cisplatin USP/BP 10 mg Vial 1 mg/ml (10ml Vol) Cisplatin USP/BP 50 mg Vial 1 mg/ml (50ml Vol) Excipients Sodium Chloride / Mannitol Isotonicity / Diuresis *Pack Sizes: Tray of 1 Vial. (Cytotoxic Packaging).
Cyclophosphamide Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Primary Use Cyclophosphamide USP/BP 200 mg Vial Low Dose / Autoimmune Cyclophosphamide USP/BP 500 mg Vial Standard Chemotherapy Cyclophosphamide USP/BP 1000 mg (1 g) Vial High Dose / Hematology Excipients Mannitol / Sodium Chloride Bulking Agent (For Cake Structure) *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials.
Cytarabine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution (Liquid) or Lyophilized Powder.
Active Ingredient Strength Format Cytarabine USP/BP 100 mg / 5 ml (20 mg/ml) Ready-to-use Liquid Cytarabine USP/BP 500 mg / 10 ml (50 mg/ml) Ready-to-use Liquid Cytarabine USP/BP 1000 mg (1 g) Vial Lyophilized Powder or Conc. Liquid Excipients Water for Injection Preservative-Free (Available for IT use) *Pack Sizes: Tray of 1 Vial, 5 Vials, or Box of 1/10 Vials.
Dacarbazine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in amber glass vials to protect from light.
Active Ingredient Strength Therapeutic Role Dacarbazine USP/BP (DTIC) 200 mg Vial Standard Dose Dacarbazine USP/BP (DTIC) 500 mg Vial High Dose / Multi-use Excipients Citric Acid, Mannitol Stabilizers / pH Adjusters *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials.
Daunorubicin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in red-capped glass vials.
Active Ingredient Strength Appearance Daunorubicin Hydrochloride USP/BP Equivalent to 20 mg Daunorubicin Red-Orange Lyophilized Cake Excipients Mannitol Bulking Agent *Pack Sizes: Tray of 1 Vial. (Cytotoxic Packaging).
Erythropoietin Prefilled Syringe Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Liquid in a Prefilled Syringe (PFS) with a fine needle.
Active Ingredient Strength (IU) Patient Profile Recombinant Human Erythropoietin 2000 IU / 0.5 ml Maintenance / Low Weight Recombinant Human Erythropoietin 4000 IU / 0.4 ml Standard Dialysis Dose Recombinant Human Erythropoietin 10000 IU / 1.0 ml Chemotherapy / High Dose Stabilizer Human Albumin / Polysorbate Prevents Protein Aggregation *Pack Sizes: Blister Pack of 1 PFS or Box of 6 PFS.
Estramustine Phosphate Capsules
FreeEstramustine phosphate capsules typically contain estramustine phosphate sodium as the active medicinal ingredient, along with several inactive excipients to ensure the drug’s stability and delivery.
Fulvestrant Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Prefilled Syringes (PFS) or Vials. (Note: This is a high-viscosity injection).
Active Ingredient Strength Volume Fulvestrant USP/BP 250 mg 5 ml Prefilled Syringe (50 mg/ml) Fulvestrant USP/BP 250 mg 5 ml Vial (50 mg/ml) Vehicle Castor Oil / Benzyl Alcohol Viscous Oily Base *Pack Sizes: Box of 1 PFS (with safety needles) or Box of 2 PFS (for 500mg dose).
Gemcitabine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Primary Use Gemcitabine Hydrochloride USP/BP Equivalent to 200 mg Gemcitabine Low Dose / Adjustment Gemcitabine Hydrochloride USP/BP Equivalent to 1000 mg (1 g) Standard Adult Dose Gemcitabine Hydrochloride USP/BP Equivalent to 1400 mg (1.4 g) High Dose / Large BSA Excipients Mannitol / Sodium Acetate Bulking Agent / Buffer *Pack Sizes: Tray of 1 Vial. (Cytotoxic Packaging).
Imatinib Capsules
FreeImatinib capsules contain the active oncology drug and a specific set of inactive ingredients designed to stabilize the compound for oral delivery.
Lenalidomide Capsules
FreeLenalidomide capsules (brand name Revlimid) are a potent immunomodulatory medication used to treat certain types of cancers, such as multiple myeloma and myelodysplastic syndromes.
Methotrexate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Isotonic Solution (Ready-to-Use) or Lyophilized Powder (High Dose).
Active Ingredient Strength Common Application Methotrexate USP/BP 2.5 mg / ml Low Dose (Rheumatology/Dermatology) Methotrexate USP/BP 25 mg / ml Standard Oncology Dose Methotrexate USP/BP 50 mg / 500 mg / 1 g High Dose MTX (Leukemia Protocols) Preservative Benzyl Alcohol Present in Multi-dose Vials (Avoid in IT use) *Pack Sizes: 2 ml Vial, 20 ml Vial, or 50 ml Vial.
Mitomycin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (Purple/Blue Cake) in amber glass vials.
Active Ingredient Strength Primary Use Mitomycin USP/BP 2 mg Ophthalmic Surgery / Pterygium Mitomycin USP/BP 10 mg Systemic Chemotherapy / Bladder Instillation Mitomycin USP/BP 20 mg / 40 mg High-Dose Bladder Protocols Excipients Mannitol Bulking Agent *Pack Sizes: Single Vial. (Must be handled with cytotoxic precautions).
Oxaliplatin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Aqueous Concentrate in glass vials. (Also available as Lyophilized Powder depending on market preference).
Active Ingredient Strength Volume Oxaliplatin USP/BP 5 mg / ml 10 ml Vial (Total 50 mg) Oxaliplatin USP/BP 5 mg / ml 20 ml Vial (Total 100 mg) Excipients Water for Injection Preservative-Free Solution *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).
Pemetrexed Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (White to Light-Yellow Cake) in glass vials.
Active Ingredient Strength Reconstitution Pemetrexed Disodium 100 mg Requires 0.9% Sodium Chloride Pemetrexed Disodium 500 mg Requires 0.9% Sodium Chloride Pemetrexed Disodium 1000 mg (1 g) High-Dose Protocols Excipients Mannitol / Hydrochloric Acid / Sodium Hydroxide Bulking Agent / pH Adjusters (pH 6.6 – 7.8) *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).
Tamoxifen Citrate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg (Equivalent to Tamoxifen Base) Standard divided-dose therapy and specific prophylactic risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg (Equivalent to Tamoxifen Base) Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Tamoxifen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg Standard divided-dose therapy and specific risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Temozolomide Capsules
FreeTemozolomide capsules are oral chemotherapy agents used primarily to treat specific types of brain tumours, such as glioblastoma multiforme and anaplastic astrocytoma. Because temozolomide is a hazardous drug, the capsules are designed to be swallowed whole to prevent direct exposure to the potent active ingredient.
Vinblastine Sulphate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (White to Off-White) or as a Ready-to-Use Liquid Solution in glass vials.
Active Ingredient Strength & Format Reconstitution / Dilution Vinblastine Sulphate USP/BP 10 mg / 10 ml (Liquid) Ready-to-use solution (1 mg/ml). Requires further dilution in 0.9% NaCl before infusion. Vinblastine Sulphate USP/BP 10 mg (Lyophilized Powder) Requires exactly 10 ml of Bacteriostatic 0.9% Sodium Chloride to yield 1 mg/ml. Excipients Sodium Chloride / Water for Injection Isotonicity / Solvent System *Pack Sizes: Single Vial encased in specialized protective cytotoxic shrink-wrap
Vincristine Sulphate Injection
FreeVincristine sulphate injection (often known by the brand Oncovin) is a sterile, preservative-free solution of a vinca alkaloid chemotherapy agent derived from the periwinkle plant. It is a clear, colourless liquid typically supplied in 1 mg or 2 mg vials.
